Avid Bioservices to Participate at Upcoming Life Sciences Industry Conferences
Details of these activities are as follows:
KNect365 Life Sciences' BioProcess International West:
Besides serving as a co-sponsor of the conference's exhibit hall opening night reception, Avid will host corporate booth #816 showcasing the company's comprehensive range of process development and high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. These include a variety of innovative processes for generating a broad range of biopharmaceutical product types such as monoclonal antibodies, highly-glycosylated recombinant proteins and enzymes, among others. These capabilities also extend to the manufacture of biosimilar products as well as antibody drug conjugate intermediates and are designed to support the overall ongoing growth of the company's contract manufacturing business.
Company representatives will provide a virtual tour of its 40,000 square foot state-of-the-art commercial biomanufacturing facility (Myford facility) for those interested. The Myford facility is designed to utilize the most cutting-edge, single-use equipment to accommodate a fully disposable biomanufacturing process for late Phase III clinical and commercial production of biologics. The facility is capable of operating in campaign mode whereby multiple bioreactors are simultaneously in operation, which increases the facility's manufacturing capacity and efficiency. The Myford facility, which was commissioned in 2016, was built to augment Avid's Franklin facility, which has been in operation since 1993 and producing cGMP commercial products since 2005.
Driving Bioprocessing Efficiency Seminar:
About Avid Bioservices
Avid Bioservices provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With over 15 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The company also provides a variety of process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. For more information about Avid, please visit www.avidbio.com.
Kelly Pisarev Lord Avid Bioservices, Inc.(800) 987-8256 Stephanie Diaz(Investors) Vida Strategic Partners415-675-7401 email@example.com Tim Brons(Media) Vida Strategic Partners415-675-7402 firstname.lastname@example.org
News Provided by Acquire Media